<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:59:16Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4681123" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4681123</identifier><datestamp>2015-12-17</datestamp><setSpec>cereatax</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cerebellum Ataxias</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cerebellum Ataxias</journal-id>
      <journal-title-group>
        <journal-title>Cerebellum &amp; Ataxias</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2053-8871</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4681123</article-id>
      <article-id pub-id-type="pmcid">PMC4681123</article-id>
      <article-id pub-id-type="pmc-uid">4681123</article-id>
      <article-id pub-id-type="pmid">26677414</article-id>
      <article-id pub-id-type="publisher-id">38</article-id>
      <article-id pub-id-type="doi">10.1186/s40673-015-0038-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spinocerebellar ataxia 28: a novel AFG3L2 mutation in a German family with young onset, slow progression and saccadic slowing</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>ZÃ¼hlke</surname>
            <given-names>Christine</given-names>
          </name>
          <address>
            <email>Christine.zuehlke@uksh.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Mikat</surname>
            <given-names>Barbara</given-names>
          </name>
          <address>
            <email>mikat@unikid.de</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Timmann</surname>
            <given-names>Dagmar</given-names>
          </name>
          <address>
            <email>dagmar.timmann@uni-due.de</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wieczorek</surname>
            <given-names>Dagmar</given-names>
          </name>
          <address>
            <email>dagmar.wieczorek@uni-due.de</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gillessen-Kaesbach</surname>
            <given-names>Gabriele</given-names>
          </name>
          <address>
            <email>G.Gillessen@uksh.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>BÃ¼rk</surname>
            <given-names>Katrin</given-names>
          </name>
          <address>
            <phone>+49 6421-58 65200</phone>
            <email>buerk@med.uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Institute of Human Genetics, University of LÃ¼beck, LÃ¼beck, Germany </aff>
        <aff id="Aff2"><label/>Institute of Human Genetics, University of Duisburg-Essen, Essen, Germany </aff>
        <aff id="Aff3"><label/>Department of Neurology, University of Essen, Essen, Germany </aff>
        <aff id="Aff4"><label/>Department of Neurology, Philipps University of Marburg, Baldinger straÃe, 53043 Marburg, Germany </aff>
        <aff id="Aff5"><label/>Paracelsus-Elena Klinik, Kassel, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>2</volume>
      <elocation-id>19</elocation-id>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© ZÃ¼hlke et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Spinocerebellar ataxia type 28 (SCA28) is related to mutations of the <italic>ATPase family gene 3</italic>-<italic>like 2</italic> gene (<italic>AFG3L2</italic>). To date, 13 private missense mutations have been identified in families of French, Italian, and German ancestry, but overall, the disorder seems to be rare in Europe. Here, we report a kindred of German ancestry with four affected family members presenting with slowly progressive ataxia, mild pyramidal tract signs and slow saccades.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>After excluding repeat expansions in the genes for SCA1-3, 6-8, 10, 12, and 17, Sanger sequencing of the coding regions of <italic>TTBK2</italic> (SCA11), <italic>KCNC3</italic> (SCA13), <italic>PRKCG</italic> (SCA14), <italic>FGF14</italic> (SCA27) and AFG3L2 (SCA28) was performed. The 17 coding exons of AFG3L2 with flanking intronic sequences were amplified by PCR and sequenced on both strands.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Sequencing detected a novel potential missense mutation (p.Y689N) in the C-terminal proteolytic domain, the mutational hotspot of AFG3L2. The online programme âPolyPhen-2â classifies this amino acid exchange as <italic>probably damaging</italic> (score 0.990). Similarly to most of the published SCA28 mutations, the novel mutation is located within exon 16. Mutations in exon 16 alter the proteolytic activity of the protease AFG3L2 that is highly expressed in Purkinje cells.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Genetic testing should be considered in dominant ataxia with pyramidal tract signs and saccadic slowing.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>AFG3L2</kwd>
        <kwd>Spinocerebellar ataxia</kwd>
        <kwd>Slow saccades</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>The spinocerebellar ataxias (SCAs) represent a clinically and genetically heterogeneous group of inherited neurological disorders with overlapping as well as highly variable phenotypes characterised by progressive incoordination, dysarthria and impaired eye movements. To date, more than 30 genetic loci have been described [<xref ref-type="bibr" rid="CR1">1</xref>]. Mutations have been isolated in 20 genes, so far. Ten SCAs are caused by repeat expansions while deletions, missense, nonsense or frame shift mutations have been identified in the remaining genes. The genetic locus for SCA28 had been mapped to chromosome 18 in 2006 [<xref ref-type="bibr" rid="CR2">2</xref>]. Meanwhile, 13 missense mutations of the <italic>ATPase family gene 3</italic>-<italic>like 2</italic> gene (<italic>AFG3L2</italic>) have been reported to cause ataxia [<xref ref-type="bibr" rid="CR3">3</xref>â<xref ref-type="bibr" rid="CR7">7</xref>]. In addition, homozygous <italic>AFG3L2</italic> mutations were identified in a spastic ataxia-neuropathy syndrome [<xref ref-type="bibr" rid="CR8">8</xref>]. Here, we describe a family of German ancestry carrying a novel AFG3L2 mutation.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results and discussion</title>
      <sec id="Sec3">
        <title>Clinical findings</title>
        <p>Onset was subtle with first symptoms not always indicative for hereditary cerebellar ataxia: the 81Â year old mother first noticed bilateral ptosis at the age of 55 that worsened over time and required blepharoplastic surgery. Patient 3 suffers from epilepsy with infrequent seizures since adolescence.</p>
        <p>Progression was usually slow with most patients remaining ambulatory several decades after onset. Saccadic slowing developed over time. For further clinical details, see TableÂ <xref rid="Tab1" ref-type="table">1</xref>. MRI studies yielded isolated cerebellar atrophy with intact brain stem and cortical structures. In two patients, there was evidence for additional small-sized white matter lesions on T2 weighted MRI images that could not be explained by vascular or inflammatory disease. Electrophysiological studies in patient 3 yielded normal motor and sensory nerve conduction velocities and amplitudes (peroneal, tibial and sural nerve).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical features</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Patient 1</th><th>Patient 2</th><th>Patient 3</th><th>Patient 4</th></tr></thead><tbody><tr><td>Sex</td><td>F</td><td>M</td><td>F</td><td>M</td></tr><tr><td>Age</td><td>81</td><td>61</td><td>59</td><td>53</td></tr><tr><td>Age of onset and<break/>First symptoms</td><td>55 ptosisâ+âfalls<break/>60 gait disturbance</td><td>24 gait disturbance</td><td>16 seizures<break/>39 gait disorder</td><td>no subjective<break/>complaints</td></tr><tr><td>Walking assistance (age)</td><td>65</td><td>60</td><td>50</td><td>â</td></tr><tr><td>Disease duration (from onset of gait disorder to physical examination)</td><td>36</td><td>37</td><td>20</td><td>?</td></tr><tr><td>MRI</td><td>Nd</td><td>Cerebellar atrophy<break/>Discrete white matter lesions<break/>(age 56)</td><td>Cerebellar atrophy<break/>Discrete white matter lesions<break/>(age 56)</td><td>Nd</td></tr><tr><td>Ataxia of stance and gait</td><td>+++</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Upper limb ataxia</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Lower limb ataxia</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Intention tremor</td><td>â</td><td>â</td><td>â</td><td>â</td></tr><tr><td>Dysarthria</td><td>(+)</td><td>++</td><td>+</td><td>+</td></tr><tr><td>Impaired smooth pursuit</td><td>Cannot be evaluated due to limitation of gaze</td><td>+</td><td>â</td><td>+</td></tr><tr><td>Gaze evoked nystagmus horizontal</td><td>Cannot be evaluated due to limitation of gaze</td><td>+</td><td>â</td><td>+</td></tr><tr><td>Impaired suppression of the vestibuloocular reflex (VOR)</td><td>â</td><td>â</td><td>+</td><td>â</td></tr><tr><td>Limitation of gaze</td><td>Vertical complete<break/>Horizontal incomplete</td><td>â</td><td>â</td><td>â</td></tr><tr><td>Saccadic slowing</td><td>++</td><td>â</td><td>++</td><td>â</td></tr><tr><td>Ptosis</td><td>+++</td><td>â</td><td>â</td><td>â</td></tr><tr><td>VI paresis</td><td>â</td><td>â</td><td>bilateral</td><td>â</td></tr><tr><td>Dysphagia</td><td>â</td><td>+</td><td>â</td><td>â</td></tr><tr><td>Hearing loss</td><td>+</td><td>â</td><td>â</td><td>â</td></tr><tr><td>Deep tendon reflexes</td><td>brisk</td><td>brisk</td><td>increased</td><td>brisk</td></tr><tr><td>Extensor plantar responses</td><td>â</td><td>â</td><td>â</td><td>â</td></tr><tr><td>Spasticity</td><td>â</td><td>â</td><td>â</td><td>â</td></tr><tr><td>Impaired noci- and thermoception</td><td>â</td><td>â</td><td>+</td><td>+</td></tr><tr><td>Impaired vibration sense</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Other symptoms</td><td>â</td><td>sleep apnea</td><td>rare seizures</td><td>â</td></tr><tr><td>SARA score [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>11/40</td><td>11/40</td><td>19/40</td><td>8/40</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Molecular genetic analysis</title>
        <p>Sequencing revealed the heterozygous mutation c.2065T&gt;A in exon 16 of the <italic>AFG3L2</italic> gene in all affected family members. The mutation segregated with the disease. On the amino acid level, this substitution results in the missense exchange p.Y689N.</p>
      </sec>
      <sec id="Sec5">
        <title>Discussion</title>
        <p>The clinical presentation in this kindred is highly compatible with the SCA28 phenotype with a slowly progressive cerebellar syndrome, hyperreflexia in the lower limbs (76Â %) and saccadic slowing (50Â %) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Saccadic slowing has been considered a typical clinical feature in SCA2 while pyramidal tract signs are usually absent [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Regarding the small sample size, further studies will be necessary to corroborate the combination of slow saccades and pyramidal tract signs as core features of SCA28. Based on these findings, we have actually suspected SCA28 in an individual with early onset and slowly progressive ataxia, saccadic slowing and pyramidal tract signs. Despite a negative family history, molecular genetic testing has actually revealed a SCA28 mutation described earlier by Di Bella and coworkers [<xref ref-type="bibr" rid="CR5">5</xref>]. Other less characteristic features include ptosis (48Â %) and impaired proprioception (45Â %) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Behavioural abnormalities and cognitive impairment have been observed in some patients. SCA28 symptoms usually start in early adulthood (mean 39Â years, SD 13) with a wide range from 3 to 60Â years. Actually, the age of onset seems to depend on the individual mutation [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p>
        <p>The <italic>AFG3L2</italic> gene, mutated in SCA28, is composed of 17 exons coding for a protein of 797 amino acids with different functional domains: an AAA consensus sequence together with an ATP/GTP-binding site, a peptidase M41 domain containing the HEXXH motif which is a characteristic feature of a zinc-dependent binding domain, and a RNA-binding region [<xref ref-type="bibr" rid="CR11">11</xref>]. AFG3L2 is highly homologous to paraplegin, the product of the <italic>SPG7</italic> gene. Mutations in the <italic>SPG7</italic> gene are responsible for a subtype of hereditary spastic paraplegia (HSP) [<xref ref-type="bibr" rid="CR12">12</xref>]. Both, AFG3L2 as well as paraplegin are metalloproteases of the AAA-superfamily; as components of the two mitochondrial AAA (m-AAA) protease isoenzymes in the inner mitochondrial membrane they are involved in the degradation of non-assembled membrane proteins as well as in the activation of mitochondrial proteins [<xref ref-type="bibr" rid="CR13">13</xref>]. Notably, 12 of 13 published SCA28 mutations correspond to missense exchanges with 11 mutations being located within exon 16 which contributes to the peptidase M41 domain [<xref ref-type="bibr" rid="CR4">4</xref>â<xref ref-type="bibr" rid="CR7">7</xref>]. They alter the proteolytic activity of the protease AFG3L2 that is highly expressed in Purkinje cells [<xref ref-type="bibr" rid="CR5">5</xref>]. The resulting mitochondrial impairment might account for the clinical similarities of SCSA28 and SPG7 with mitochondrial disorders. Two or even three different mutations affecting amino acids at positions 666, 671, and 689 have been identified in SCA28 patients to date. The variation p.Y689N (c.2065T&gt;A) present in our family, is not listed in the integrated map of genetic variation from 1092 human genomes (1000genomes.org). Interestingly, another mutation affecting the tyrosine residue at position 698 (p.Y689H) has recently been identified in another SCA28 patient [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Based on these findings, the missense mutation p.Y689N is likely to have a pathogenic impact on the SCA28 phenotype. This assumption is supported by the strong conservation of tyrosine (Y) at position 689 e.g. in monkey, mouse, dog, elephant, opossum, chicken and zebrafish (UCSC Genome Browser, hg19). Furthermore, the online programme âPolyPhen-2â classifies this amino acid exchange as <italic>probably damaging</italic> (score 0.990).</p>
    </sec>
    <sec id="Sec7" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Subjects</title>
        <p>Clinical data and blood samples were obtained in four affected individuals (mother: patient 1, three of four children: patients 2 to 4, details see TableÂ <xref rid="Tab1" ref-type="table">1</xref>) and one unaffected sibling (57Â years at examination, SARA score 0/40, personally examined by DT). The study was approved by the Institutional review board of University of LÃ¼beck.</p>
      </sec>
      <sec id="Sec9">
        <title>Genetic analysis</title>
        <p>After having obtained informed consent, genomic DNA was extracted from peripheral blood leukocytes by standard protocols. According to the EFNS guidelines [<xref ref-type="bibr" rid="CR14">14</xref>] prior to sequence analysis, expansions at the loci for SCA1, 2, 3, 6, 7, 8, 10, 12, and 17 were excluded. Additional Sanger sequencing of the coding regions of <italic>TTBK2</italic> (SCA11), <italic>KCNC3</italic> (SCA13), <italic>PRKCG</italic> (SCA14), and <italic>FGF14</italic> (SCA27) identified only known polymorphisms and SNPs. For AFG3L2, the 17 coding exons with flanking intronic sequences were also amplified by PCR and sequenced on both strands. Pathogenic mutations in SPTBN2 (SCA5), KCND3 (SCA19/22), PDYN (SCA23), and ITPR1 (SCA29) genes have not tested in this kindred but a pathogenic impact appears less likely for one of these genes with respect to phenotype characteristics and geographical restrictions (at least in some of these genotypes).</p>
      </sec>
      <sec id="Sec10">
        <title>Data bases</title>
        <p>Ensembl AFG3L2 ENSG00000141385, transcript ENST00000269143. HGMD biobase: <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/">www.hgmd.cf.ac.uk</ext-link>; UCSC genome browser: <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu</ext-link>; 1000 genomes: <ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org/">www.1000genomes.org</ext-link>; PolyPhen-2âprediction of functional effects of human nsSNPs: <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>.</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>Christine ZÃ¼hlke and Barbara Mikat contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare no conflicts of interest.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ contributions</bold>
        </p>
        <p>CZ, BM and GG carried out the molecular genetic studies and helped to draft the manuscript. DT and DW performed clinical examinations and helped to draft the manuscript. KBÂ and CZ participated in the design of the study. KB, performed the clinical examinations and drafted the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank the patients and their family for supplying blood samples for scientific research.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matilla-Duenas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Corral-Juan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davalos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Latorre</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias</article-title>
          <source>Cerebellum</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>148</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1007/s12311-009-0144-2</pub-id>
          <?supplied-pmid 19890685?>
          <pub-id pub-id-type="pmid">19890685</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cagnoli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mariotti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Taroni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brussino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Michielotto</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>235</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awh651</pub-id>
          <?supplied-pmid 16251216?>
          <pub-id pub-id-type="pmid">16251216</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mariotti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brusco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Di Bella</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cagnoli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Seri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gellera</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis</article-title>
          <source>Cerebellum</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>184</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s12311-008-0053-9</pub-id>
          <?supplied-pmid 18769991?>
          <pub-id pub-id-type="pmid">18769991</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edener</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wollner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hehr</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kohl</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kreuz</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation</article-title>
          <source>Eur J Hum Genet</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>965</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1038/ejhg.2010.40</pub-id>
          <?supplied-pmid 20354562?>
          <pub-id pub-id-type="pmid">20354562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Bella</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lazzaro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brusco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Plumari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Battaglia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pastore</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28</article-title>
          <source>Nat Genet</source>
          <year>2010</year>
          <volume>42</volume>
          <fpage>313</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.544</pub-id>
          <?supplied-pmid 20208537?>
          <pub-id pub-id-type="pmid">20208537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cagnoli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stevanin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brussino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barberis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>RL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Missense mutations in the AFG3L2 proteolytic domain account for approximately 1.5Â % of European autosomal dominant cerebellar ataxias</article-title>
          <source>Hum Mutat</source>
          <year>2010</year>
          <volume>31</volume>
          <fpage>1117</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.21342</pub-id>
          <?supplied-pmid 20725928?>
          <pub-id pub-id-type="pmid">20725928</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobbe</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Hilker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hackstein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nolte</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28</article-title>
          <source>J Mol Neurosci</source>
          <year>2014</year>
          <volume>52</volume>
          <fpage>493</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1007/s12031-013-0187-1</pub-id>
          <?supplied-pmid 24293060?>
          <pub-id pub-id-type="pmid">24293060</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pierson</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bonn</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cherukuri</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Teer</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases</article-title>
          <source>PLoS Genet</source>
          <year>2011</year>
          <volume>7</volume>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1002325</pub-id>
          <?supplied-pmid 22022284?>
          <pub-id pub-id-type="pmid">22022284</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wadia</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mankodi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chamberlain</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis</article-title>
          <source>Brain</source>
          <year>1998</year>
          <volume>121</volume>
          <issue>Pt 12</issue>
          <fpage>2341</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/121.12.2341</pub-id>
          <?supplied-pmid 9874485?>
          <pub-id pub-id-type="pmid">9874485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iwabuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shiojiri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Otagiri</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Electrophysiological features of central motor conduction in spinocerebellar atrophy type 1, type 2, and Machado-Joseph disease</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1998</year>
          <volume>65</volume>
          <fpage>530</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.65.4.530</pub-id>
          <?supplied-pmid 9771779?>
          <pub-id pub-id-type="pmid">9771779</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banfi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bassi</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Andolfi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marchitiello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zanotta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ballabio</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification and characterization of AFG3L2, a novel paraplegin-related gene</article-title>
          <source>Genomics</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>51</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1999.5818</pub-id>
          <?supplied-pmid 10395799?>
          <pub-id pub-id-type="pmid">10395799</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casari</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Fusco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ciarmatori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zeviani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mora</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>93</volume>
          <fpage>973</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81203-9</pub-id>
          <?supplied-pmid 9635427?>
          <pub-id pub-id-type="pmid">9635427</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nolden</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ehses</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koppen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bernacchia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rugarli</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>277</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.003</pub-id>
          <?supplied-pmid 16239145?>
          <pub-id pub-id-type="pmid">16239145</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gasser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baets</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Van Broeckhoven</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Di Donato</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias</article-title>
          <source>Eur J Neurol</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>179</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2009.02873.x</pub-id>
          <?supplied-pmid 20050888?>
          <pub-id pub-id-type="pmid">20050888</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmitz-Hubsch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>du Montcel</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Baliko</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Berciano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Depondt</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Scale for the assessment and rating of ataxia: development of a new clinical scale</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>1717</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000219042.60538.92</pub-id>
          <?supplied-pmid 16769946?>
          <pub-id pub-id-type="pmid">16769946</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>